Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Synthomer predicts revenue decline amid challenges

Tue, 30th Jan 2024 12:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Berkeley Energia Ltd - Spain-focused clean energy company, focused on bringing the Salamanca project in Western Spain to production - Spot uranium prices jump 27% in the quarter to December 31, ending at USD91 per pound, and further rise to about USD100 per pound in January. "The outlook for nuclear power and the uranium market continued to strengthen during the quarter," Berkeley Energia says. Meanwhile, disagrees with decision by High Court of Justice of Castilla y Leon in Spain. The court upheld appeals to revoke judgements for authorisation of exceptional use of the land and the urbanism licence. Berkeley Energia plans to appeal the judgement at Spain's Supreme Court under Spanish law "to defend its position and take all necessary actions to preserve its rights."

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health - Swings to adjusted operating profit of GBP900,000 in 2023 from a loss of GBP2.1 million in 2022. Revenue grows 7.1% to GBP13.5 million in 2023 from GBP12.6 million. Looking ahead, company says: "There has been considerable merger & acquisition activity by large pharmaceutical companies in the central nervous system drug development sector recently and, together with an improving global economic outlook, that is expected to prompt further investment in CNS clinical trials." Chief Executive Officer Matthew Stork adds: "Despite challenging market conditions during 2023, the company has strengthened its technology platforms and commercial offering and is positioned to capitalise on the anticipated growth in the CNS drug development market. We continue to focus on delivering profitable growth and driving success over the medium-term." Cambridge Cognition will release its 2023 results in April.

----------

Diversified Energy Co PLC - owner of US oil and gas wells - Average net daily production edges up 1.3% to 136,800 barrels of oil equivalent in 2023, from 135,000 in 2022. Estimated adjusted earnings before interest, tax, depreciation and amortisation are set to rise at least 7.4% to between USD540 million and USD545 million in 2023, from USD503 million in 2022. CEO Rusty Hutson says: "Despite a challenging commodity price environment, we generated strong full year results, including growing Ebitda to a record level that exceeded consensus expectations," adding: "Diversified continues to grow as a solutions-based business, making it the right company at the right time."

----------

Flowtech Fluidpower PLC - Wilmslow, England-based supplier of technical fluid power products - Revenue in Great Britain declines 6.2% to GBP79.3 million in 2023, from GBP84.5 million in 2022. In Ireland, revenue climbs 13% to GBP22.0 million from GBP19.5 million. In the Benelux countries, revenue edges up 0.5% to GBP10.8 million. The company says that underlying profit for 2023 is anticipated to be in line with market expectations. Cites market expectations of underlying earnings before interest and tax of GBP6.0 million and underlying pretax profit of GBP4.6 million. Chair Roger McDowell says: "In 2023, we welcomed Mike England as our new CEO. With some significant team changes, he has focussed on implementing the near term performance improvement plan and the refreshed strategy to enable the firm platform from which the business can grow over the medium term. Whilst 2023 has been a more difficult year, I am confident that the actions Mike and his team are taking will drive strong returns in shareholder value."

----------

Harworth Group PLC - focused on the regeneration of land and property for sustainable development and investment - Expects EPRA net disposal value as at December 31 to be slightly ahead of current market consensus of 194.0 pence, which has a range of 189.5p to 195.6p. For December 31, 2022, the company had reported an EPRA NDV of 196.5p. The company says that its anticipated EPRA NDV "is the result of management actions undertaken on development sites to unlock high value uses, and positive progress with planning applications, which have underpinned valuation gains". Chief Executive Officer Lynda Shillaw says: "As we enter 2024, there are some signs of optimism in the macro environment whilst our key markets remain characterised by structural undersupply. We are encouraged that we are seeing continued good demand into the new year for our serviced residential land as well as occupier interest in our employment sites."

----------

Synthomer PLC - Essex, England-based chemicals manufacturer - Anticipates revenue decline of 16% to GBP2.0 billion in 2023 from GBP2.38 billion in 2022. Adjusted Ebitda will be between GBP140 million and GBP144 million in 2023. For 2022, Synthomer had reported Ebitda of GBP249.2 million. Year-end net debt is expected to decrease 51% to GBP499 million, ahead of its own expectations, from GBP1.02 billion a year prior. Synthomer cites "strong cash delivery in the final quarter" for the net debt reduction. The company says trading in the fourth quarter was consistent with trends throughout the year, with subdued volumes and limited visibility amid ongoing challenging macroeconomic conditions in the chemicals industry. Looking ahead, CEO Michael Willome says: "In the near term, our focus remains on enhancing our strong positions in key speciality end-markets, optimising our business portfolio and cost position, and sustaining our demonstrated ability to generate free cash flow despite the challenging demand environment."

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
13 Sep 2022 15:59

UK earnings, trading statements calendar - next 7 days

Wednesday 14 September 
Advanced Medical Solutions Group PLCHalf Year Results
Anpario PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 15 September 
Big Technologies PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Checkit PLCHalf Year Results
DFS Furniture PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Gresham House PLCHalf Year Results
Hilton Food Group PLCHalf Year Results
IG Group Holding PLCQ1 Results
IGas Energy PLCHalf Year Results
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
MJ Gleeson PLCFull Year Results
Oxford BioMedica PLCHalf Year Results
Portmeirion Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Renishaw PLCFull Year Results
RTW Venture Fund LtdHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Wickes Group PLCHalf Year Results
Friday 16 September 
Dunedin Enterprise Investment Trust PLCHalf Year Results
Monday 19 September 
City of London Investment Group PLCFull Year Results
Craneware PLCFull Year Results
Haleon PLCHalf Year Results
IQGeo Group PLCHalf Year Results
Tuesday 20 September 
Alliance Pharma PLCHalf Year Results
ASA International Group PLCHalf Year Results
Belluscura PLCHalf Year Results
Brown Advisory US Smaller Cos PLCFull Year Results
Cambridge Cognition Holdings PLCHalf Year Results
EKF Diagnostics Holdings PLCHalf Year Results
Elixirr International PLCHalf Year Results
Feedback PLCFull Year Results
Fintel PLCHalf Year Results
First Tin PLCHalf Year Results
Frasers Group PLCFull Year Results
Gaming Realms PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Henry Boot PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
Jadestone Energy PLCHalf Year Results
Kingfisher PLCHalf Year Results
Litigation Capital Management LtdFull Year Results
Moonpig PLCTrading Statement
Northcoders Group PLCHalf Year Results
Spectral MD Holdings LtdHalf Year Results
SThree PLCTrading Statement
Unbound Group PLCHalf Year Results
Xaar PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Sep 2022 18:00

IN BRIEF: Cambridge Cognition wins follow-on GBP2.2 million contract

Cambridge Cognition Holdings PLC - Cambridge-based brain health assessment software provider - Wins GBP2.2 million contract for providing cognitive assessments and electronic diaries for a neurodegenerative disease trial.

Read more
17 Aug 2022 10:31

Cambridge Cognition products to be used in Alzheimer's study

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday announced a collaboration for its NeuroVocalix and CANTAB products.

Read more
28 Jul 2022 20:54

TRADING UPDATES: Virgin Wines loses fizz; M&C revenue improves

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jul 2022 14:04

Director dealings: Cambridge Cognition execs invest after solid update

(Sharecast News) - Cambridge Cognition was among a relatively thin list of director deals on Friday afternoon, after two of its executives made share purchases.

Read more
21 Jul 2022 13:18

Cambridge Cognition half-year revenue jumps 31%, order book grows

(Alliance News) - Cambridge Cognition Holdings PLC on Thursday said revenue grew strongly in the first half of 2022.

Read more
8 Jun 2022 21:23

TRADING UPDATES: Altona Rare Earths positive on Monte Maumbe project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Jun 2022 16:04

UK shareholder meetings calendar - next 7 days

Thursday 2 June  
Clontarf Energy PLCGM re issue of new shares
HealthBeacon PLCAGM
Friday 3 June  
no events scheduled  
Monday 6 June  
Alphawave IP Group PLCAGM
Minoan Group PLCAGM
Omega Diagnostics Group PLCAGM
Sensyne Health PLCGM re strategic financing
Tuesday 7 June  
Animalcare Group PLCAGM
Arix Bioscience PLCAGM
Centrica PLCAGM
Integrated Diagnostics Holdings PLCAGM
Kooth PLCAGM
Ondine Biomedical IncAGM
Osirium Technologies PLCAGM
SpaceandPeople PLCAGM
TruFin PLCAGM
Wednesday 8 June  
Ascent Resources PLCAGM
Cambridge Cognition Holdings PLCAGM
City Pub Group PLCAGM
DP Eurasia NVAGM
Gem Diamonds LtdAGM
Hiro Metaverse Acquisitions I SAAGM
Itaconix PLCAGM
M&G Credit Income Investment Trust PLCAGM
Nostrum Oil & Gas PLCAGM
Parity Group PLCAGM
Petards Group PLCAGM
Safestyle UK PLCAGM
Savannah Resources PLCAGM
Third Point Investors LtdAGM
Woodbois LtdAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 Apr 2022 12:42

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
6 Apr 2022 17:26

IN BRIEF: Cambridge Cognition appoints new chief financial officer

Cambridge Cognition Holdings PLC- Cambridge-based neuroscience technology company - Appoints Stephen Symonds as chief financial officer with effect "in due course".

Read more
5 Apr 2022 16:34

UK earnings, trading statements calendar - next 7 days

Wednesday 6 April  
Applied Graphene Materials PLCHalf Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Hilton Food Group PLCFull Year Results
Hyve Group PLCTrading Statement
Topps Tiles PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 7 April 
Alpha Financial Markets Consulting PLCTrading Statement
Attraqt Group PLCFull Year Results
Entain PLCQ1 Results
Robert Walters PLCQ1 Results
Tracsis PLCHalf Year Results
Friday 8 April 
CMC Markets PLCTrading Statement
Ferrexpo PLCTrading Statement
Monday 11 April 
Tortilla Mexican Grill PLCFull Year Results
Sirius Real Estate LtdTrading Statement
Tuesday 12 April 
ASOS PLCHalf Year Results
Cambridge Cognition Holdings PLCFull Year Results
Destiny Pharma PLCFull Year Results
easyJet PLCTrading Statement
Filta Group Holdings PLCFull Year Results
JD Sports Fashion PLCFull Year Results
Liontrust Asset ManagementTrading Statement
M Winkworth PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Nanoco Group PLCHalf Year Results
Pennon Group PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Mar 2022 12:41

Cambridge Cognition wins phase 3 contract worth over £1m

(Sharecast News) - Brain health technology developer Cambridge Cognition has won a contract worth just over £1m with an unnamed "top 10" pharmaceutical company, it announced on Monday, to provide digital cognitive assessments for a pivotal phase 3 autoimmune disease trial.

Read more
28 Mar 2022 10:11

IN BRIEF: Cambridge Cognition wins GBP1 million contract

Cambridge Cognition Holdings PLC- Cambridge, neuroscience technology company - Wins contract with an unnamed "top 10" pharmaceutical company. The contract worth over GBP1 million will see Cambridge Cognition provide digital cognitive assessments for a phase III autoimmune disease trial. Revenue from the contract is expected over the next three years.

Read more
28 Mar 2022 10:02

AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
27 Mar 2022 10:38

Sunday share tips: Cambridge Cognition Holdings, FRP

(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.